Novartis Becomes The First To Link Sustainability Bond To A ‘Social Goal’
Novartis’ bond sale raises “1.85 billion” euro to expand malaria and leprosy treatment.
Novartis’ bond sale raises “1.85 billion” euro to expand malaria and leprosy treatment.
The battle for eradicating malaria is on. ExxonMobil continues to fight relentlessly against the disease worldwide grip. The good news is that its efforts are now having a measurable impact. Mortality rates due to malaria have come down dramatically. But the war, is not won yet, and ExxonMobil fights on.